Sanofi - American Depositary Shares (SNY) closed at $48.43 on November 11, 2026, up 0.4% from the previous close, on volume of 2,237,122 shares (30-day average 4,394,620).
Data as of November 11, 2026.
11-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 9, 2026 | Call with Delta Hedge | 15-Jan-27 52.5 C +72,000 Stock | 3,000 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
PRNewswire (Thu, 29-Oct 7:30 AM ET)
Sanofi (SNY) Teams With ScionxBio to Pursue Long-Acting mRNA Candidates Using the TERA Platform
Market Chameleon (Tue, 20-Oct 5:29 AM ET)
ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics
Business Wire (Tue, 20-Oct 9:10 AM ET)
PRNewswire (Thu, 15-Oct 12:01 PM ET)
Market Chameleon (Thu, 15-Oct 3:10 AM ET)
Globe Newswire (Wed, 14-Oct 9:45 AM ET)
PRNewswire (Fri, 2-Oct 11:59 AM ET)
Sanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investment
PRNewswire (Wed, 16-Sep 10:31 AM ET)
PRNewswire (Thu, 10-Sep 9:07 AM ET)
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.
As of November 11, 2026, SNY stock price climbed to $48.43 with 2,237,122 million shares trading.
SNY has a beta of -0.04, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.00 to the broad based SPY ETF.
SNY has a market cap of $115.93 billion. This is considered a Large Cap stock.
Last quarter Sanofi - American Depositary Shares reported $17 billion in Revenue and $2.04 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $.41.
In the last 3 years, SNY traded as high as $60.12 and as low as $39.07.
The top ETF exchange traded funds that SNY belongs to (by Net Assets): AVDE, PPH, FVD, FENI, PID.
SNY has underperformed the market in the last year with a return of +0.4%, while SPY returned +12.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SNY shares. However, SNY has outperformed the market in the last 3 month and 2 week periods, returning +11.4% and +15.6%, while SPY returned -1.5% and -1.3%, respectively. This indicates SNY has been having a stronger performance recently.
SNY support price is $47.38 and resistance is $49.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.
